Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia-Pacific, Europe, the Middle East, Africa, and South America. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, motorcycles, trucks, and boats. This segment also produces other activated carbon products for use in various applications, including food, water, beverage, and chemical purification. The Performance Chemicals segment develops, manufactures, and sells a range of specialty chemicals derived from co-products of the kraft pulping process and caprolactone monomers. This segment's products are used in various applications comprising warm mix paving, pavement preservation, pavement reconstruction and recycling, oil well service additives, oil production, and downstream applications; and adhesives, agrochemical dispersants, lubricants, printing inks, coatings, resins, elastomers, bioplastics, medical devices, and other industrial applications. Ingevity Corporation was incorporated in 2015 and is headquartered in North Charleston, South Carolina.
IPO Year: 2016
Exchange: NYSE
Website: ingevity.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/26/2025 | $62.00 → $65.00 | Market Perform → Outperform | BMO Capital Markets |
| 8/7/2024 | $58.00 | Market Perform → Market Outperform | CJS Securities |
| 4/22/2024 | $52.00 → $62.00 | Hold → Buy | Jefferies |
| 11/6/2023 | $49.00 | Market Outperform → Market Perform | CJS Securities |
| 10/3/2023 | $62.00 → $53.00 | Buy → Hold | Loop Capital |
| 8/7/2023 | $71.00 → $60.00 | Outperform → Market Perform | BMO Capital Markets |
| 7/27/2023 | $64.00 → $75.00 | Hold → Buy | Loop Capital |
| 5/5/2023 | $92.00 → $64.00 | Buy → Hold | Loop Capital |
| 2/2/2023 | $81.00 → $100.00 | Hold → Buy | Loop Capital |
| 10/11/2022 | $89.00 → $87.00 | Outperform | BMO Capital Markets |
HIGHLIGHTS: Net sales of $284.0 million, down 17% compared to prior year, primarily due to repositioning actions in Performance Chemicals, which included the exit of certain lower-margin end markets Net income of $20.5 million and diluted earnings per share (EPS) of $0.56 reflects before-tax special charges of $20.2 million; adjusted earnings of $36.4 million and diluted adjusted EPS of $0.99 Adjusted EBITDA of $91.3 million increased 23% and adjusted EBITDA margin improved to 32.1% due primarily to the successful execution of repositioning actions in Performance Chemicals and continued strong profitability in Performance Materials Operating cash flow of $25.4 million with free cash
Ingevity Corporation (NYSE:NGVT) announced today that it will release its first-quarter 2025 earnings after the stock market close on Monday, May 5, 2025. The company will host a live webcast on Tuesday, May 6, at 9:00 a.m. (Eastern) to discuss first-quarter 2025 fiscal results. The webcast can be accessed here or on the investors section of Ingevity's website. Participants may also listen to the conference call by dialing 833 470 1428 (inside the U.S.) and entering access code 815699. Callers outside the U.S. can find global dial-in numbers here. For those unable to join the live event, a recording will be available beginning at approximately 2:00 p.m. (Eastern) on May 6, 2025, through M
Board and Management Team Have Taken Significant and Decisive Action to Respond to External Market Challenges Key Transformational Changes Are Driving Strong Financial Results and Stock Price Outperformance Continued Execution of Proven Strategy Positions Ingevity to Unlock Significant Additional Stockholder Value Company Urges Stockholders to Vote "FOR" ONLY Ingevity's Highly Qualified Director Nominees on the WHITE Proxy Card Launches VoteIngevity.com Providing Additional information for Stockholders Ingevity Corporation (NYSE:NGVT) today announced that it has filed its definitive proxy statement with the U.S. Securities and Exchange Commission in connection with its 2025 Annual Meet
Li brings 25-year+ record of driving successful corporate transformation, long-term growth and stockholder value creation at premier global specialty materials supplier Ingevity Corporation (NYSE:NGVT) today announced that its board of directors has appointed David H. Li as the company's president and CEO, effective as of April 7, 2025, and that he is expected to join the board of directors following the 2025 Annual Meeting. Li succeeds Ingevity board member, Luis Fernandez-Moreno, who has been serving as interim president and CEO since October 2024. Fernandez-Moreno will remain on Ingevity's board. This press release features multimedia. View the full release here: https://www.businesswir
Delivered Record Year in Performance Materials and Strategic Repositioning in Performance Chemicals Is Already Demonstrating Results Business Portfolio Review Is Progressing with Recently Announced Strategic Alternatives Process for Industrial Specialties Product Line and Evaluation of Additional Portfolio and Cost Reduction Actions Ongoing Provides Information About Engagement with Vision One Ingevity Corporation (NYSE:NGVT) today issued the following letter to stockholders in response to the presentation issued by Vision One Management Partners ("Vision One") earlier today: Dear Ingevity Stockholders, The Ingevity Board of Directors and leadership team are committed to taking ag
Fourth Quarter: Net sales of $298.8 million decreased 20% compared to prior year primarily due to repositioning actions in the Performance Chemicals segment that resulted in the exit of lower-margin end markets Net income of $16.6 million and diluted earnings per share (EPS) of $0.46, including pre-tax restructuring charges of $23.4 million; adjusted earnings of $34.7 million and diluted adjusted EPS of $0.95 Adjusted EBITDA of $80.6 million and adjusted EBITDA margin of 27.0% Operating cash flow of $64.5 million and free cash flow of $39.6 million, which included the second and final $50.0 million installment of a termination fee for a long-term crude tall oil (CTO) supply agreemen
Ingevity (NYSE:NGVT) today announced it has been named as one of "America's Most Responsible Companies of 2025" by Newsweek magazine for the third consecutive year. This prestigious award recognizes the top 600 publicly traded companies headquartered in the United States for their commitment to making a positive global impact. "We are honored to be recognized by Newsweek as one of America's Most Responsible Companies for 2025," said Luis Fernandez-Moreno, Ingevity interim president and CEO. "Ingevity was founded on products that contribute to safeguarding our environment, and this achievement highlights our company's further commitments to pursuing excellence in governance, prioritizing o
Exiting of targeted product line expected to further strengthen the Performance Chemicals segment and improve Ingevity's overall earnings and cash flow profile Evaluating additional potential actions to maximize shareholder value Full year 2024 Net sales expected to be approximately $1.40 billion; Adjusted EBITDA of approximately $360 million Ingevity Corporation (NYSE:NGVT) today announced that it is exploring strategic alternatives for the company's Performance Chemicals Industrial Specialties product line, including a potential divestiture of portions of its North Charleston site. Ingevity noted that this process includes all Industrial Specialties pine chemical-based chemistri
Ingevity Corporation (NYSE:NGVT) announced today that it will release its fourth-quarter and full year 2024 earnings after the stock market closes on Tuesday, February 18, 2025. The company will host a live webcast on Wednesday, February 19, at 10:00 a.m. (Eastern) to discuss Ingevity's fourth-quarter and full year 2024 fiscal results. The webcast can be accessed here or on the investors section of Ingevity's website. Participants may also listen to the conference call by dialing 833 470 1428 (inside the U.S.) and entering access code 068901. Callers outside the U.S. can find global dial-in numbers here. For those unable to join the live event, a recording will be available beginning at
Accomplished chemical industry CFO brings substantial finance and capital management expertise and experience driving corporate transformation Ingevity Corporation (NYSE:NGVT) today announced the election of J. Kevin Willis to the board of directors effective today. With Mr. Willis's election, the Board now includes nine directors, eight of whom are independent. Mr. Willis is senior vice president and chief financial officer (CFO) at Ashland Inc. (NYSE:ASH), a global additives and specialty ingredients company serving a wide range of consumer and industrial markets, including architectural coatings, automotive, construction, energy, food and beverage, nutraceuticals, personal care and p
BMO Capital Markets upgraded Ingevity from Market Perform to Outperform and set a new price target of $65.00 from $62.00 previously
CJS Securities upgraded Ingevity from Market Perform to Market Outperform and set a new price target of $58.00
Jefferies upgraded Ingevity from Hold to Buy and set a new price target of $62.00 from $52.00 previously
CJS Securities downgraded Ingevity from Market Outperform to Market Perform and set a new price target of $49.00
Loop Capital downgraded Ingevity from Buy to Hold and set a new price target of $53.00 from $62.00 previously
BMO Capital Markets downgraded Ingevity from Outperform to Market Perform and set a new price target of $60.00 from $71.00 previously
Loop Capital upgraded Ingevity from Hold to Buy and set a new price target of $75.00 from $64.00 previously
Loop Capital downgraded Ingevity from Buy to Hold and set a new price target of $64.00 from $92.00 previously
Loop Capital upgraded Ingevity from Hold to Buy and set a new price target of $100.00 from $81.00 previously
BMO Capital Markets resumed coverage of Ingevity with a rating of Outperform and set a new price target of $87.00 from $89.00 previously
SC 13G/A - Ingevity Corp (0001653477) (Subject)
SC 13G/A - Ingevity Corp (0001653477) (Subject)
SC 13D/A - Ingevity Corp (0001653477) (Subject)
SC 13G/A - Ingevity Corp (0001653477) (Subject)
SC 13G - Ingevity Corp (0001653477) (Subject)
SC 13G - Ingevity Corp (0001653477) (Subject)
SC 13G/A - Ingevity Corp (0001653477) (Subject)
SC 13D/A - Ingevity Corp (0001653477) (Subject)
SC 13G/A - Ingevity Corp (0001653477) (Subject)
SC 13G/A - Ingevity Corp (0001653477) (Subject)
HIGHLIGHTS: Net sales of $284.0 million, down 17% compared to prior year, primarily due to repositioning actions in Performance Chemicals, which included the exit of certain lower-margin end markets Net income of $20.5 million and diluted earnings per share (EPS) of $0.56 reflects before-tax special charges of $20.2 million; adjusted earnings of $36.4 million and diluted adjusted EPS of $0.99 Adjusted EBITDA of $91.3 million increased 23% and adjusted EBITDA margin improved to 32.1% due primarily to the successful execution of repositioning actions in Performance Chemicals and continued strong profitability in Performance Materials Operating cash flow of $25.4 million with free cash
Ingevity Corporation (NYSE:NGVT) announced today that it will release its first-quarter 2025 earnings after the stock market close on Monday, May 5, 2025. The company will host a live webcast on Tuesday, May 6, at 9:00 a.m. (Eastern) to discuss first-quarter 2025 fiscal results. The webcast can be accessed here or on the investors section of Ingevity's website. Participants may also listen to the conference call by dialing 833 470 1428 (inside the U.S.) and entering access code 815699. Callers outside the U.S. can find global dial-in numbers here. For those unable to join the live event, a recording will be available beginning at approximately 2:00 p.m. (Eastern) on May 6, 2025, through M
Fourth Quarter: Net sales of $298.8 million decreased 20% compared to prior year primarily due to repositioning actions in the Performance Chemicals segment that resulted in the exit of lower-margin end markets Net income of $16.6 million and diluted earnings per share (EPS) of $0.46, including pre-tax restructuring charges of $23.4 million; adjusted earnings of $34.7 million and diluted adjusted EPS of $0.95 Adjusted EBITDA of $80.6 million and adjusted EBITDA margin of 27.0% Operating cash flow of $64.5 million and free cash flow of $39.6 million, which included the second and final $50.0 million installment of a termination fee for a long-term crude tall oil (CTO) supply agreemen
Exiting of targeted product line expected to further strengthen the Performance Chemicals segment and improve Ingevity's overall earnings and cash flow profile Evaluating additional potential actions to maximize shareholder value Full year 2024 Net sales expected to be approximately $1.40 billion; Adjusted EBITDA of approximately $360 million Ingevity Corporation (NYSE:NGVT) today announced that it is exploring strategic alternatives for the company's Performance Chemicals Industrial Specialties product line, including a potential divestiture of portions of its North Charleston site. Ingevity noted that this process includes all Industrial Specialties pine chemical-based chemistri
Ingevity Corporation (NYSE:NGVT) announced today that it will release its fourth-quarter and full year 2024 earnings after the stock market closes on Tuesday, February 18, 2025. The company will host a live webcast on Wednesday, February 19, at 10:00 a.m. (Eastern) to discuss Ingevity's fourth-quarter and full year 2024 fiscal results. The webcast can be accessed here or on the investors section of Ingevity's website. Participants may also listen to the conference call by dialing 833 470 1428 (inside the U.S.) and entering access code 068901. Callers outside the U.S. can find global dial-in numbers here. For those unable to join the live event, a recording will be available beginning at
HIGHLIGHTS: Net sales of $376.9 million, down 16% compared to prior year, primarily due to repositioning actions in Performance Chemicals Net loss of $107.2 million and diluted loss per share of $2.95 reflects before-tax restructuring charges of $86.9 million and contract termination fees of $100.0 million; adjusted earnings of $40.2 million and diluted adjusted earnings per share (EPS) of $1.10 Adjusted EBITDA of $106.4 million and adjusted EBITDA margin of 28.2% Operating cash flow of $46.5 million with free cash flow of $28.5 million Affirms full year guidance of sales between $1.40 billion and $1.50 billion and adjusted EBITDA between $350 million and $360 million The result
Ingevity Corporation (NYSE:NGVT) announced today that it will release its third-quarter 2024 earnings after the stock market close on Tuesday, October 29, 2024. The company will host a live webcast on Wednesday, October 30, at 10:00 a.m. (Eastern) to discuss third-quarter 2024 fiscal results. The webcast can be accessed here or on the investors section of Ingevity's website. You may also listen to the conference call by dialing 833 470 1428 (inside the U.S.) and entering access code 381718. Callers outside the U.S. can find global dial-in numbers here. For those unable to join the live event, a recording will be available beginning at approximately 2:00 p.m. (Eastern) on October 30, 2024,
Will optimize existing manufacturing footprint by consolidating oleo-based chemical refining with existing crude tall oil refining at the company's North Charleston, South Carolina, facility, and closing its Crossett, Arkansas, facility in August Manufacturing consolidation will result in approximately $20 million to $25 million in annual savings beginning in 2025 Executes corporate and business-related cost reduction actions resulting in additional annual savings of approximately $10 million beginning in 2025 Expects charges associated with these actions of approximately $100 million, with approximately $65 million to be non-cash Continues to evaluate the Performance Chemicals
HIGHLIGHTS: Net sales of $390.6 million, down 19% compared to prior year Net loss of $283.7 million and diluted loss per share of $7.81 primarily due to a Performance Chemicals non-cash goodwill impairment charge; adjusted earnings of $36.8 million and diluted adjusted earnings per share (EPS) of $1.01 Adjusted EBITDA of $101.3 million and adjusted EBITDA margin of 25.9% Operating cash flow of $29.7 million with free cash flow of $11.6 million In July, the company took further actions to reposition its Performance Chemicals segment, including the termination of a long-term crude tall oil supply contract, the announced closure of its Crossett, Arkansas, facility, to consolidat
Ingevity Corporation (NYSE:NGVT) announced today that it will release its second-quarter 2024 earnings after the stock market close on Wednesday, July 31, 2024. The company will host a live webcast on Thursday, August 1, at 11:00 a.m. (Eastern) to discuss second-quarter 2024 fiscal results. The webcast can be accessed here or on the investors section of Ingevity's website. You may also listen to the conference call by dialing 833 470 1428 (inside the U.S.) and entering access code 153840. Callers outside the U.S. can find global dial-in numbers here. For those unable to join the live event, a recording will be available beginning at approximately 2:00 p.m. (Eastern) on August 1, 2024, t
4 - Ingevity Corp (0001653477) (Issuer)
4 - Ingevity Corp (0001653477) (Issuer)
4 - Ingevity Corp (0001653477) (Issuer)
4 - Ingevity Corp (0001653477) (Issuer)
4 - Ingevity Corp (0001653477) (Issuer)
4 - Ingevity Corp (0001653477) (Issuer)
4 - Ingevity Corp (0001653477) (Issuer)
4 - Ingevity Corp (0001653477) (Issuer)
4 - Ingevity Corp (0001653477) (Issuer)
4 - Ingevity Corp (0001653477) (Issuer)
Board and Management Team Have Taken Significant and Decisive Action to Respond to External Market Challenges Key Transformational Changes Are Driving Strong Financial Results and Stock Price Outperformance Continued Execution of Proven Strategy Positions Ingevity to Unlock Significant Additional Stockholder Value Company Urges Stockholders to Vote "FOR" ONLY Ingevity's Highly Qualified Director Nominees on the WHITE Proxy Card Launches VoteIngevity.com Providing Additional information for Stockholders Ingevity Corporation (NYSE:NGVT) today announced that it has filed its definitive proxy statement with the U.S. Securities and Exchange Commission in connection with its 2025 Annual Meet
Li brings 25-year+ record of driving successful corporate transformation, long-term growth and stockholder value creation at premier global specialty materials supplier Ingevity Corporation (NYSE:NGVT) today announced that its board of directors has appointed David H. Li as the company's president and CEO, effective as of April 7, 2025, and that he is expected to join the board of directors following the 2025 Annual Meeting. Li succeeds Ingevity board member, Luis Fernandez-Moreno, who has been serving as interim president and CEO since October 2024. Fernandez-Moreno will remain on Ingevity's board. This press release features multimedia. View the full release here: https://www.businesswir
Delivered Record Year in Performance Materials and Strategic Repositioning in Performance Chemicals Is Already Demonstrating Results Business Portfolio Review Is Progressing with Recently Announced Strategic Alternatives Process for Industrial Specialties Product Line and Evaluation of Additional Portfolio and Cost Reduction Actions Ongoing Provides Information About Engagement with Vision One Ingevity Corporation (NYSE:NGVT) today issued the following letter to stockholders in response to the presentation issued by Vision One Management Partners ("Vision One") earlier today: Dear Ingevity Stockholders, The Ingevity Board of Directors and leadership team are committed to taking ag
Ingevity Corporation (NYSE:NGVT) today announced that John Fortson has departed as president and chief executive officer and from the board of directors of the company, effective as of October 2, 2024. The board of directors has appointed current board director, Luis Fernandez-Moreno as interim president and chief executive officer while it conducts a search for a permanent replacement. "On behalf of the entire board, I want to thank John for his leadership and dedication to Ingevity over the past nine years," said Jean Blackwell, chair of the board of directors. "Under John's guidance, Ingevity successfully transitioned into a standalone public company, expanded its global footprint and e
Ingevity Corporation (NYSE:NGVT) today announced the appointment of Ryan C. Fisher as senior vice president, general counsel and secretary and Terry Dyer as senior vice president and chief human resources officer. "We are excited to add Ryan and Terry to our executive leadership team," said Ingevity president and CEO, John Fortson. "Both leaders bring extensive experience, with successful track records of leading companies through business growth and expansion. I am confident that their contributions will be instrumental in driving our continued success and innovation." Fisher has held various leadership positions during his 18-year tenure with Ingevity and its predecessors. Most recent
Allegion plc (NYSE:ALLE), a leading global security products and solutions provider, has appointed Stacy Cozad as senior vice president, general counsel and corporate secretary, effective Aug. 5, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240701071652/en/Stacy Cozad (Photo: Business Wire) In this role, Cozad will have responsibility for Allegion's global legal affairs, trade compliance, enterprise risk management and corporate communications functions. She will succeed Jeff Braun, who has announced plans to retire on Dec. 31, 2024, and will serve as an advisor during the transition. Cozad has nearly 30 years of exper
Ingevity Corporation (NYSE:NGVT) today announced it has named Christine Stunyo, formerly with Host Hotels & Resorts, as chief human resources officer. In this role, Stunyo will be responsible for leading the company's global Human Resources (HR) function, including organization development, integrated talent management, leadership development and culture. She assumes the new role effective June 27, 2022. "We are thrilled to welcome Christine to Ingevity to lead our outstanding human resources team," said John Fortson, Ingevity president and CEO. "She will be instrumental in continuing our commitment to diversity, equity and inclusion, drawing the best talent to Ingevity, and helping to dev
Ingevity Corporation (NYSE:NGVT) today announced that effective March 1, 2022, Mike Smith has elected to retire as executive vice president and president, Performance Chemicals, strategy and business development. Beginning January 1, 2022, Rich White, vice president, Industrial Specialties, and Steve Hulme, vice president, Engineered Polymers, at Ingevity will co-lead the company's Performance Chemicals segment. At that time, White will become senior vice president, Performance Chemicals, and president, Industrial Specialties and Pavement Technologies, and Hulme will be senior vice president, Performance Chemicals, and president, Engineered Polymers. "Mike has been an integral member of ou
S-8 - Ingevity Corp (0001653477) (Filer)
S-8 POS - Ingevity Corp (0001653477) (Filer)
10-Q - Ingevity Corp (0001653477) (Filer)
8-K - Ingevity Corp (0001653477) (Filer)
8-K - Ingevity Corp (0001653477) (Filer)
SCHEDULE 13G/A - Ingevity Corp (0001653477) (Subject)
DEFA14A - Ingevity Corp (0001653477) (Filer)
8-K - Ingevity Corp (0001653477) (Filer)
DEFA14A - Ingevity Corp (0001653477) (Filer)
DEFC14A - Ingevity Corp (0001653477) (Subject)